Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Infection
Carrimycin may be a bright alternative for CRAB infection as one of the drugs in combination therapy, especially in a patient with hyperinflammatory response.
Authors
- Ning Du (ORCID: https://orcid.org/0000-0003-3025-4629)
- Yihui Wang (ORCID: https://orcid.org/0000-0001-5665-5557)
- Juan He (ORCID: https://orcid.org/0000-0001-9430-4766)
- Dava Tenzing
- Jun Meng
- Dongxiang Qu
- Dan You
Institutions
- Qiqihar University (CN)
- Shanghai Jiao Tong University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Ruijin Hospital (CN)
- National Cancer Center (US)
- Hegang People's Hospital (CN)
- People's Hospital of Shiyan (CN)
- Qiqihar Medical University (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2024-08-01
- DOI
- https://doi.org/10.2147/idr.s468413
- Citations
- 3
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.51
Funders
- National Natural Science Foundation of China
- Shanghai Jiao Tong University
- Natural Science Foundation of Heilongjiang Province
- China International Medical Foundation
- Ruijin Hospital